[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Adverum Biotechnologies, Inc. Common Stock (ADVM)
Adverum Biotechnologies completes ARTEMIS trial screening, but the stock price falls. Market sentiment is mixed, with some bullish on the pipeline and others concerned about the price drop and micro-cap status.
About Adverum Biotechnologies, Inc. Common Stock
Adverum Biotechnologies, Inc. Common Stock (ADVM) is a stock in the healthcare sector.
Adverum Biotechnologies, Inc. Common Stock uses the ticker $ADVM for trading. Listed in the Stocks and category.
Insights #
- Adverum Biotechnologies, Inc. Common Stock (ADVM) social dominance is up XXX% from the previous month.
- Adverum Biotechnologies, Inc. Common Stock (ADVM) galaxy score™ is up XXXXX% from the previous week.
Price: $XXXX #
Price 24-Hour Time-Series Raw Data
The price decline of -XXXXX% today appears to be related to the completion of screening for the ARTEMIS trial, despite the generally positive news, the market may be reacting to the details of the announcement or other factors.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | -XXXXX% | XXXX% |
1-Year High: $XXXX on 2024-10-18
1-Year Low: $XXXX on 2025-05-15
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
Adverum Biotechnologies, Inc. Common Stock (ADVM) is currently AltRank #408 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX +354
1 Month: XXX -XXX
6 Months: XXX -XXXXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-09-11
1-Year Low: XX on 2025-01-01
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +15
1 Month: XX +3
6 Months: XX no change
1 Year: XX +20
1-Year High: XX on 2025-06-02
1-Year Low: XX on 2025-06-22
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX +83%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXX -XX%
1-Year High: XXXXX on 2024-11-19
1-Year Low: X on 2025-01-27
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
6 Months: XXX -XX%
1 Year: XXXXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2025-09-13
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Adverum Biotechnologies, Inc. Common Stock (ADVM) in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
6 Months: XXX +99%
1 Year: XXXXX +160%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-05-24
The most influential creators that mention Adverum Biotechnologies, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biobeats99 | X | XXX | XX | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% +2%
1-Year High: XXX% on 2024-10-16
1-Year Low: X% on 2025-02-11
Most Supportive Themes
- Positive Clinical Trial News: (45%) Positive sentiment surrounding the completion of screening for the ARTEMIS trial and potential for accelerated timelines.
- Gene Therapy Pipeline Progress: (30%) Focus on the progress of the gene therapy pipeline, specifically the potential of ixoberogene soroparvovec for wet AMD.
Most Critical Themes
- Price Decline: (10%) The stock price has declined recently, with some posts mentioning negative price movement.
- Micro-Cap Concerns: (5%) Mentions of the company being a micro-cap stock, which can be a concern for some investors.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | X% | XXX | XX% | X | X% |
| Total | XX | X% | XXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXXX% +0.00172%
1 Month: XXXXX% +0.0015%
6 Months: XXXXX% -XXXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2024-10-22
1-Year Low: XXXXXX% on 2025-09-13
Market Dominance: XXXXXXXXXXXXXXXXXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2024-10-18
1-Year Low: XXXXXXX% on 2025-10-14
Market Cap: $XXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXX
Daily Average: $XXXXXXXXXX
1 Week: $XXXXXXXXXX -$8.20%
1 Month: $XXXXXXXXXX +$55%
6 Months: $XXXXXXXXXX +$63%
1 Year: $XXXXXXXXXX -$38%
1-Year High: $XXXXXXXXXXX on 2024-10-18
1-Year Low: $XXXXXXXXXX on 2025-05-15
Top assets mentioned In the posts about Adverum Biotechnologies, Inc. Common Stock in the last XX hours
BioMarin Pharmaceutical, Inc. (BMRN) Aaon Inc (AAON) Bluefin (BLUE) Helius Medical Technologies, Inc. Class A Common Stock (DE) (HSDT) CRISPR Therapeutics AG (CRSP) Intellia Therapeutics, Inc (NTLA) Krystal Biotech, Inc. Common Stock (KRYS) Protagonist Therapeutics, Inc (PTGX) Amicus Therapeutics, Inc (FOLD)
Top topics mentioned In the posts about Adverum Biotechnologies, Inc. Common Stock in the last XX hours
stocks healthcare, coins defi, investment, coins dao, telegram, $bmrn, $adus, $clpt, $aaon, $abat, $dxy, coins solana ecosystem, $vtyx, $bdtx, sentiment, $blue, coins nft, $atnm, $prld, $hsdt, stocks crypto treasuries, $klrs, $crsp, $ntla, stocks, $krys, $ptgx, $trda, $rgbp, $ehgo, $ksiof, $ksi, $aiio, $glue, $apvo, $caba, $autl, $fate, $fold, $zyme, regeneron pharmaceuticals inc, $kymr, $kura, bank of america, $xbi, $ibb, $labu, $sdgr, alt aptoslaunch token, $alt, $alec, $dnli, $txg, $atnf, magic eden, superrarebears
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"This is so well put @ProfitGrand Thank you $TXG $ATNF $ME $TSVT $FDMT $SXTP $ETNB $AADI $AARD $ABCL $ABEO $ABSI $ABVC $ACIU $AXDX $SLRN $ACHV $ACHL $ACRS $ACRV $ACTU $ABOS $ACXP $ADAG $ACET $ADTX $ANL $ADVM $AVTE $AFMD $AGEN $AIMD $AKTX $AKBA $AKYA $TCRT $ALDX"
X Link @BuyTheUgly 2025-10-14T16:25Z XX followers, XXX engagements
"WB $DNLI Tivi Priority Review PDUFA Extended Due to Clinical Pharmacology Request Full report in Telegram (in bio)👆 $BLUE $ARWR $VRTX $BMRN $SRPT $IONS $ALNY $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR $ZLAB"
X Link @Biobeats99 2025-10-13T23:18Z XXX followers, XXX engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (3/3). $ALT Phase 2b $ALEC Phase X $ADVM Phase X $ZBIO Phase X $PCVX Phase X $RARE Phase X $TRAW Phase X $GPCR Phase 2b $SLS Phase X $RHHBY Phase X $MREO Phase X $KMDA Phase X $INSM Phase X $ATOS Phase X $ARTV Phase 2a $ALZN Phase X $AGIO Phase X $ADCT Phase X $TLPH Phase X $STOK Phase X $RLMD Phase X $REGN Phase 2/3 $PBYI Phase X $PBYI Phase X $NVS Phase X $NAMS Phase X $NAMS Phase X $NAMS Phase X $MRNA Phase X $INKT Phase X $LSTA Phase 2b $KZIA Phase X $JAZZ Phase X $IONS Phase X $INAB Phase X $IMMP Phase 2/3 $GNFT Phase X $FBIO"
X Link @BiopharmIQ 2025-10-12T20:36Z 27.3K followers, XXX engagements
"William Blair CRISPR Therapeutics AG (CRSP) - Preclincial AATD Data Showcases SyNTase Platform and Suggests Patients May Be Able to Achieve Normal Serum AAT Levels Full report in Telegram (in bio)☝ (Tickers: $CRSP $EDIT $NTLA $BEAM $VERV $ARWR $ALNY $IONS $BLUE $RGNX $QURE $ABEO $PGEN $DNLI $FATE $SGMO $ADVM $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR $ZLAB $EVGN $EXEL $KPTI $IMCR $ABCL $SWTX $OMGA $RNA $ARCT $ALLK $INZY $MNOV $KURA $BMRN $SRPT $VRTX $DNA $RXRX)"
X Link @Biobeats99 2025-10-11T22:08Z XXX followers, XXX engagements